-+ 0.00%
-+ 0.00%
-+ 0.00%

AlzeCure Pharma to present at Swiss Nordic Bio 2026 conference

PUBT·09/22/2026 08:02:04
Diffusion vocale
AlzeCure Pharma to present at Swiss Nordic Bio 2026 conference
  • AlzeCure will present at Swiss Nordic Bio 2026 in Zurich on Oct. 1, 2026.
  • CEO Martin Jönsson will provide a business update tied to recent Alzheimer’s-related collaboration and outlicensing deals with Eli Lilly, QuantumCell.
  • One-on-one meetings with investors, potential partners are scheduled alongside the conference.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzeCure Pharma AB published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.